Medicare Announces Reimbursement Rates for Coronavirus Testing

The Centers for Medicare & Medicaid Services (CMS) announced the reimbursement rates that health care providers will receive for COVID-19 testing. Find out what this means for you.

Published March 16, 2020

Follow our Medicare Coronavirus News page for related information on coronavirus (COVID-19) and its impact on Medicare beneficiaries.

The Centers for Medicare and Medicaid Services (CMS) recently announced that testing for COVID-19 would be fully covered. Private health insurance companies soon followed suit. 

Find a $0 premium Medicare Advantage plan today.

Speak with a licensed insurance agent


On March 16, the CMS released details about how COVID-19 testing would be reimbursed to health care providers administering the tests. 

Laboratories using the test developed by the Center for Disease Control and Prevention (CDC) would be reimbursed $36 per test. Those using a non-CDC test will be reimbursed $51 per test.

CMS noted that the exact reimbursement amounts may vary slightly according to the local Medicare Administrative Contractor (MAC), but all local rates are within a dollar of the above rates. Providers will rely on the established reimbursement rates for their region until a national payment rate is installed. 

Medicare coverage of COVID-19

COVID-19 testing is covered by Medicare Part B when a test is ordered by a doctor or other health care provider. The Part B deductible will not apply, as the COVID-19 test falls under the category of clinical diagnostic laboratory tests that are included under Part B coverage.

Medicare Advantage plans (Medicare Part C) are required by law to provide at least the same benefits as Original Medicare. This means that Medicare Advantage plans also cover the cost of COVID-19 tests. 

Medicare billing for COVID-19 testing

In addition to the reimbursement amounts, CMS also made clear the Healthcare Common Procedure Coding System (HCPCS) billing codes that would be used to identify COVID-19 testing for labs and health care providers. 

Code U0001 identifies diagnostic testing performed by laboratories using a CDC-developed COVID-19 test. Code U0002 will be used for all non-CDC lab test for COVID-19, including those developed in-house according to new Federal Drug Administration (FDA) guidelines.

Health care providers administering COVID-19 tests must wait until April 1 to submit a claim to Medicare. 

COVID-19 testing for other insurance

Private health insurers, Medicaid and the Children’s Health Insurance Program (CHIP) will also be covering COVID-19 tests at no cost. And the CDC announced that it will not be charging any out-of-pocket costs to uninsured persons for the test. 

You can learn more about Medicare Advantage plans and the benefits they offer by calling to speak with a licensed insurance agent. You can also compare plans that are available where you live online, with no obligation to enroll.

Find Medicare plans in your area

Compare Plans

Or call TTY Users: 711 to speak with a licensed insurance agent. We accept calls 24/7!


About the author

Christian Worstell is a licensed insurance agent and a Senior Staff Writer for He is passionate about helping people navigate the complexities of Medicare and understand their coverage options.

His work has been featured in outlets such as Vox, MSN, and The Washington Post, and he is a frequent contributor to health care and finance blogs.

Christian is a graduate of Shippensburg University with a bachelor’s degree in journalism. He currently lives in Raleigh, NC.

Where you've seen coverage of Christian's research and reports:

MarketWatch logo

Yahoo Finance logo 


WebMD Logo

South Florida Sun Sentinel Logo Logo

Deseret News Logo

Healthcare Finance Logo